Akumin Inc. (AKU): Price and Financial Metrics
GET POWR RATINGS... FREE!
AKU Stock Summary
- Of note is the ratio of Akumin Inc's sales and general administrative expense to its total operating expenses; merely 0.41% of US stocks have a lower such ratio.
- For AKU, its debt to operating expenses ratio is greater than that reported by 99.54% of US equities we're observing.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AKU comes in at -550.23% -- higher than that of merely 0.46% of stocks in our set.
- Stocks that are quantitatively similar to AKU, based on their financial statements, market capitalization, and price volatility, are NGG, HE, CGBD, GBDC, and PNNT.
- AKU's SEC filings can be seen here. And to visit Akumin Inc's official web site, go to www.akumin.com.
AKU Valuation Summary
- AKU's price/sales ratio is 0.6; this is 84.21% lower than that of the median Healthcare stock.
- Over the past 51 weeks, AKU's price/earnings ratio has gone down 37.4.
- Over the past 51 weeks, AKU's price/sales ratio has gone down 0.2.
Below are key valuation metrics over time for AKU.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| AKU | 2021-08-31 | 0.6 | 1.1 | -7.5 | 97.0 |
| AKU | 2021-08-30 | 0.6 | 1.2 | -7.8 | 97.9 |
| AKU | 2021-08-27 | 0.6 | 1.2 | -7.7 | 97.7 |
| AKU | 2021-08-26 | 0.6 | 1.2 | -8.0 | 98.6 |
| AKU | 2021-08-25 | 0.6 | 1.2 | -7.9 | 98.4 |
| AKU | 2021-08-24 | 0.6 | 1.2 | -7.9 | 98.3 |
AKU Price Target
For more insight on analysts targets of AKU, see our AKU price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $5.15 | Average Broker Recommendation | 1.38 (Strong Buy) |
AKU Stock Price Chart Interactive Chart >
AKU Price/Volume Stats
| Current price | $1.63 | 52-week high | $4.10 |
| Prev. close | $1.61 | 52-week low | $1.48 |
| Day low | $1.60 | Volume | 25,200 |
| Day high | $1.63 | Avg. volume | 62,680 |
| 50-day MA | $1.71 | Dividend yield | N/A |
| 200-day MA | $2.48 | Market Cap | 145.11M |
Akumin Inc. (AKU) Company Bio
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.
Latest AKU News From Around the Web
Below are the latest news stories about Akumin Inc that investors may wish to consider to help them evaluate AKU as an investment opportunity.
Akumin Inc. to Present at the 40th Annual J.P. Morgan Health Care ConferenceAkumin Inc. (NASDAQ: AKU) (TSX: AKU) is pleased to announce that Riadh Zine, Chairman & Co-CEO, and Rhonda Longmore-Grund, President & Co-CEO, will present virtually at the 40th Annual J.P. Morgan Health Care Conference on Wednesday, January 12, 2022, at 2:15pm EST. |
Is Akumin Inc. (TSE:AKU) Popular Amongst Insiders?If you want to know who really controls Akumin Inc. ( TSE:AKU ), then you'll have to look at the makeup of its share... |
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Akumin Inc. (AKU) on Behalf of InvestorsLOS ANGELES, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Akumin Inc. (“Akumin” or the “Company”) (NASDAQ: AKU) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Akumin investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your c |
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Akumin Inc. (AKU) on Behalf of InvestorsBENSALEM, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Akumin Inc. (“Akumin” or the “Company”) (NASDAQ: AKU) investors concerning the Company’s possible violations of federal securities laws. On Sunday, August 15, 2021, Akumin announced that it would not timely file its financial report for the period ended June 30, 2021 because the Company requires “additional information and analysis relate[d] to potential additional credit loss |
Akumin Announces 2022 Financial Guidance and Files Corporate Presentation Following the Acquisition of Alliance Healthcare ServicesAkumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") is pleased to announce today its full-year 2022 financial guidance, following the previously announced closing of the Alliance Healthcare Services, Inc. ("Alliance") acquisition. The Alliance acquisition closed on September 1, 2021, and Consolidated Financial Results for the quarter ended September 30th, 2021, which includes only one month of Alliance results, were released on December 13th, 2021. |
AKU Price Returns
| 1-mo | -3.55% |
| 3-mo | -20.10% |
| 6-mo | -48.09% |
| 1-year | -44.93% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -6.86% |
| 2021 | -41.86% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...